The Balchem Corp (BCPC) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered BCPC. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for BCPC is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned BCPC 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Balchem Corp to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BCPC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
ram selvaraju H.C. Wainwright | Buy | $135.0 | reiterated | Oct 30, 2023 |
mitra ramgopal Sidoti | Buy | $175.0 | upgraded | Feb 22, 2022 |
mark connelly Stephens | Hold | $145.0 | downgraded | Aug 2, 2021 |
brett hundley Seaport Global | Hold | None | initiatedcoverage | Feb 21, 2019 |
mike ritzenthaler Piper Sandler | Buy | $71.0 | maintained | Feb 2, 2016 |
daniel rizzo Jefferies | Buy | None | upgraded | Apr 1, 2014 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
When did it IPO
0
Staff Count
1,297
Country
United States
Sector/Industry
Basic Materials/Specialty Chemicals
CEO
Mr. Theodore L. Harris
Market Cap
$4.96B
In 2023, BCPC generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BCPC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
EEFT-USD
$106.39
IAC-USD
$57.18
PTEN-USD
$12.06
IPAR-USD
$152.65
EXLS-USD
$30.26
COLM-USD
$81.5